El Confidencial also cited unidentified sources from the government who said that it does not back the transaction, though its scope to intervene is limited. The government fears losing its influence over the Spanish motorways, which will depend on decisions taken in Italy, the report said.
In addition to Spain's loss of influence in matters such as tariff negotiations, decision-making on new investments or out-of-court settlements, there is an unease in the government because the first message conveyed was that Atlantia and Abertis intended a merger. The reality, however, is that Atlantia will take over Abertis through a EUR 16.5 per share cash offer that values 100% of the Spanish group at EUR 16.34bn.
Legal sources told El Confidencial that the government's influence in this area is practically null, since the takeover has no corporate effects on the capital structure of the concessionaires, whose controlling shareholder will remain Abertis.
After Hours Summary: GES +16%, PSTG +11%, WSM +9%, PVH +3.6%, HPQ +3% following earnings/guidance, INFO +5% on S&P 500 addition news, AERI +27% on Ph 3 trial update... BF.B -1.6% CEO denies sale speculationAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: GES +16.1%, PSTG +10.7%, WSM +8.8%, SBLK +6.2%, CSRA +4.6%, PVH +3.6%, HPQ +3.1%, MOD +3.1%, FSM +3%, SCVL +1.9%, PLUS +1.3%
Companies trading higher in after hours in reaction to news: AERI +27.3% (reports 'successful' primary efficacy results of the 90-day Phase 3 'Mercury 2' registration trial for Roclatan), IDXG +7.3% (is launching a new biomarker to be ordered along with its current molecular thyroid testing options), GLBS +5.4% (continued strength), INFO +4.7% (will replace TEGNA in the S&P 500), GWPH +4.4% (GW Pharma and subsidiary Greenwich Biosciences announce publication of study of Epidiolex in The New England Journal of Medicine; significantly reduced convulsive seizure frequency), EPE +3.7% (announces joint venture with Tesoro to fund oil and natural gas development in Altamont program; the companies also signed a multi-year Crude Oil Supply Agreement), MEIP +3% (initiated with an Outperform at Raymond James), RDUS +2.8% (announced positive top-line results from the completed 24 month ACTIVExtend trial, which met all of its primary and secondary endpoints), IRT +2.2% (will replace Ultratech in the S&P SmallCap 600), SPKE +1.5% (authorized share buyback program of up to $50 mln of Class A common stock), PBYI +1.4% (continued strength), DVMT +0.6% and CRM +0.4% (Salesforce.com and Dell Technologies announced a strategic technology agreement-Salesforce's Intelligent Customer Success Platform to connect Dell sales, service, marketing and more), COL +0.4% (initiated with Outperform at Bernstein; tgt $129), LYV +0.4% (ticking higher, initiated with a Buy at Guggenheim), TRI +0.3% (received approval for the annual renewal of its normal course issuer bid)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: UHAL -3.1% (light volume), NTAP -2.7%, CPRT -2.7%
Companies trading lower in after hours in reaction to news: CMRE -8.5% (plans to offer 12.5 mln shares of its common stock; the Konstantakopoulos family, who in the aggregate own a majority of the shares, have indicated their intention to purchase approximately $10 million of shares in the offering), CORI -6.8% (to sell shares of common stock in an underwritten public offering), SPEX -5.6% (files for $3 mln common stock offering), EVLV -3.3% (announces $4.5 mln registered direct offering of common stock), HOS -2.7% (will be replaced in the S&P SmallCap 600), OZRK -2.4% (agreed to sell 6.6 million shares of its common stock in an underwritten registered public offering), SUI -2% (commences an underwritten public offering of 3,500,000 shares of its common stock), BF.B -1.6% (CEO reiterates that Brown-Forman is not for sale), SNAP -0.9% (Snap under pressure on reports of advertising discounts)
Closing Market Summary: S&P 500 Closes at Record HighEquities posted their fifth consecutive win on Wednesday with the S&P 500 (+0.3%) jumping to a new record high. The Nasdaq (+0.4%) and the Dow (+0.4%) also settled with modest gains after the FOMC minutes for the May 2-3 meeting led to an uptick in buying interest in the afternoon session.
The FOMC minutes revealed that Committee members agree that it will soon be appropriate to begin reducing the central bank's massive balance sheet, and provided a possible straightforward approach to do so. Currently, the central bank is holding the balance sheet steady by reinvesting the principal of maturing securities. But, by the end of the year, the Fed would like to introduce a gradual increase of caps to limit the reinvestment.
Taking steps to reduce the Fed's balance sheet would add to the tightening effect from rising rates, but it is worth noting that the plan revealed in the minutes is not as aggressive as it could be if the Fed decided to stop reinvestments altogether. The Fed's willingness to discuss the issue shows that the central bank has pretty good confidence in the economic outlook, having attributed first quarter weakness to transitory factors.
The fed funds futures market still points to the June FOMC meeting as the most likely time for the next rate-hike announcement with an implied probability of 83.1%, up from yesterday's 78.5%.
U.S. Treasuries took the FOMC minutes in stride, hitting their best levels of the day following the release; the benchmark 10-yr yield slipped two basis points to 2.26%. Meanwhile, the U.S. Dollar Index (97.01, -0.28) moved lower in tandem with interest rates and the CBOE Volatility Index (VIX 9.99, -0.73, 6.8%) dropped below the 10.00 mark.
In the equity market, the S&P 500 drifted within a three-point range going into the FOMC minutes, but then moved to a fresh session high following the release. Eight of eleven sectors settled in positive territory, however, sector leadership was weak. The lightly-weighted materials (+0.7%), utilities (+0.7%), and real estate (+0.6%) spaces paced the advanced while the top-weighted technology (+0.5%) and financials (unch) sectors failed to really distinguish themselves.
The energy (-0.4%) sector settled with the telecom services group (-0.7%) at the bottom of the day's leaderboard as crude oil fell 0.3% to $51.35/bbl. The Energy Information Administration (EIA) reported a larger than expected draw in U.S. crude stocks for the week ended May 19 (-4.4 million barrels actual vs -2.4 million barrels consensus). However, the report prompted little to no movement as investors remained cautious ahead of tomorrow's OPEC/non-OPEC production meeting.
In U.S. corporate news, retailers slipped after producing another largely disappointing batch of earnings; Lowe's (LOW 79.85, -2.49) lost 3.0% on downbeat earnings, Tiffany & Co. (TIF 85.03, -8.11) lost 8.7% on worse than expected revenues, and Advance Auto Parts (AAP 133.02, -7.64) dropped 5.4% after missing top and bottom line estimates. The SPDR S&P 500 Retail ETF (XRT 40.40, -0.15) lost 0.4% while the consumer discretionary sector (+0.4%) finished a tick above the broader market.
The remaining sectors--industrials (+0.1%), health care (+0.2%), and consumer staples (+0.5%)--finished the session with modest gains.
On the data front, investors received several economic reports on Wednesday, including April Existing Home Sales, the March FHFA Housing Price Index, and the weekly MBA Mortgage Applications Index:
- Existing home sales for April decreased 2.3% from March to an annualized rate of 5.57 million units while the consensus expected a reading of 5.65 million. The prior month's reading was revised to 5.70 million from 5.71 million.
- The key takeaway from the report remains the same: existing home sales are being impeded by a lack of affordable supply, particularly in the lower- and mid-market price range.
- The FHFA Housing Price Index for March increased 0.6%, which followed an unrevised increase of 0.8% in February.
- The weekly MBA Mortgage Applications Index increased 4.4% to follow last week's 4.1% decrease.
Tomorrow, investors will receive Initial Claims (consensus 238,000) and April Advance International Trade in Goods. Both reports will cross the wires at 8:30 ET.
- Nasdaq Composite +14.5% YTD
- S&P 500 +7.4% YTD
- Dow Jones Industrial Average +6.3% YTD
- Russell 2000 +1.9% YTD
How Safran saved its takeover bid on ZodiacFour months after the launch of its takeover bid on Zodiac, the French engine manufacturer has revised its offer down by about 15%. To save an operation undermined by the activism of the TCI fund and the profit warning of Zodiac.The boat pitched, squeaked, but it finally held tight. After four months of storm, between the new warnings on Zodiac results and the relentless guerrilla campaign led by the TCI activist fund against the deal, Safran finally managed to build a new takeover bid for Zodiac Aerospace. To save his operation, the French engine manufacturer made two major changes. One, he reduced the proposed price to 25 euros per share, 5 euros less than announced on 19 January (29.47 euros). Safran is offering 8.7 billion euros, one billion less than in January, which represents a discount of 15%, as the Tribune had unveiled Wednesday morning .Secondly, the French aeronautics group has simplified its offer. That of January was based on a complex mechanism, with a takeover bid and then a merger, allowing Zodiac shareholders to benefit from the tax advantages of the Dutreil pact. The TCI fund had made this mechanism a casus belli, ensuring that it introduced an unequal treatment between shareholders. Safran now offers a more traditional offer: a cash offer at € 25 per share, uncapped, and a subsidiary offer, in Safran shares, limited to 31.4% of the capital of Zodiac, with a prohibition on sale Of shares for three years.TCI GuerrillaThe offer was validated unanimously by the boards of the two groups, and the operation seems to be saved. The contrary winds had multiplied in four months. First, TCI's repeated attacks on the operation. The British activist fund multiplied the letters to the members of Safran's board, some even threatening to prosecute them if they continued to support the operation. TCI even assured in a report published in early May that Zodiac was worth no more than 6 to 8 euros per share, and in no case more than 10 euros ... This all-out offensive had been reinforced by the new warnings on result of Zodiac, related To new problems on aircraft seat activity, which had the effect of a cold shower on the operation.Ross McInnes, the Chairman of the Board, and Philippe Petitcolin, CEO of Safran, finally stood firm. The interest of the operation is intact, they assure in chorus. "We have been listening to our shareholders since January and have taken their remarks into account when they are constructive," said Ross McInnes, quoted in the statement. "We are absolutely convinced of the strategic logic of the operation." According to the group, the integration of Zodiac by Safran should even make it possible to resolve more quickly the crisis of activity seats and interiors of aircraft. "I personally visited recently several industrial sites of Zodiac in Europe and in the United States to verify that the skills of Safran will solve the current difficulties," says Philippe Petitcolin in the release. However, Ross McInnes acknowledged that the recovery of the margins of Zodiac could take "one or two years" more than envisaged last January. "There will probably be a loss of markets, but the fundamentals are good," assures the Chairman of Safran.200 million annual synergiesFor the rest, the group's managers were careful to reassure the shareholders of the group. One, Safran maintained its target of 200 million euros in synergies per year, of which 90% three years after completion of the operation and 100% over five years, thanks to "optimization of international locations" , In clear the rationalization of the many factories of Zodiac. Two, he confirmed his promise to launch a share buyback program worth € 2.3 billion over two years. Three, he insists to continue to pay 40% of his net profit in dividends, and promises to remain in the investment grade rating agencies.The track seems free for a finalization of the offer in early January 2018. What to content the two camps: Safran gets his hand on a long-sought-after target, which had refused his advances on several occasions. As for Zodiac, he spares himself the trauma of a failure of the operation. At the end of April, the group announced the development of a plan B, based on maintaining the group's independence, to the former CEO of Faurecia Yann Delabrière. But this scenario would probably have resulted in a sharp fall in the Zodiac title, as markets no longer hide their mistrust for a group that has accumulated eleven warnings on results in two and a half years.Departure from Zarrouati after the operationZodiac CEO Olivier Zarrouati, who was to become number two in the group merged under the terms of the first offer, should eventually let go of the group once the deal is finalized. As for the family shareholders of Zodiac, they should bring their shares to the Safran offer. "The majority should opt for the offer of securities, and thus become shareholders of Safran," assures a source close to Zodiac. Only a few family shareholders (5% of the maximum share capital) should remain Zodiac's shareholders for an indefinite period, pending the launch of a mandatory withdrawal operation.
Comment Safran a sauvé son OPA sur Zodiac{https://www.challenges.fr/entreprise/aeronautique/comment-safran-a-sauve-son-opa-sur-zodiac_475648}Quatre mois après le lancement de son OPA sur Zodiac, le motoriste français a revu son offre à la baisse, de 15% environ. De quoi sauver une opération mise à mal par l'activisme du fonds TCI et les profit warning de Zodiac.Le bateau a tangué, grincé, mais il a finalement tenu bon. Après quatre mois de tempête, entre les nouveaux avertissements sur résultats de Zodiac et l’implacable guérilla menée par le fonds activiste TCI contre l’opération, Safran est finalement parvenu à construire une nouvelle offre de rachat de Zodiac Aerospace. Pour sauver son opération, le motoriste français a effectué deux changements majeurs. Un, il a réduit le prix proposé à 25 euros par action, soit 5 euros de moins que celui annoncé le 19 janvier (29,47 euros). Safran propose ainsi 8,7 milliards d'euros, soit un milliard de moins qu'en janvier, ce qui représente une décote de 15%, comme l’avait dévoilé la Tribune mercredi matin.Deuxième changement de fond, le groupe aéronautique français a simplifié son offre. Celle de janvier était basée sur un mécanisme complexe, avec une OPA, puis une fusion, ce qui permettait aux familles actionnaires de Zodiac de bénéficier des avantages fiscaux du pacte Dutreil. Le fonds TCI avait fait de ce mécanisme un casus belli, assurant qu’elle introduisait une inégalité de traitement entre les actionnaires. Safran propose désormais une offre plus classique: une offre en cash à 25 euros l’action, non plafonnée, et une offre subsidiaire, en titres Safran, limitée à 31,4% du capital de Zodiac, et assortie d’une interdiction de cession des actions durant trois ans.Guérilla de TCIL’offre ayant été validée à l’unanimité des conseils des deux groupes, l’opération semble bel et bien sauvée. Les vents contraires s’étaient pourtant multipliés depuis quatre mois. D’abord, les attaques répétées de TCI contre l’opération. Le fonds activiste britannique a multiplié les lettres aux membres du conseil de Safran, certaines les menaçant même de poursuites s’ils continuaient de soutenir l’opération. TCI assurait même dans un rapport publié début mai que Zodiac ne valait pas plus de 6 à 8 euros l’action, et en aucun cas plus de 10 euros… Cette offensive tous azimuts avait été renforcée par les nouveaux avertissements sur résultat de Zodiac, liés à de nouveaux problèmes sur l’activité sièges d’avions, qui avaient fait l’effet d’une douche froide sur l’opération.Ross McInnes, le président du conseil, et Philippe Petitcolin, DG de Safran, ont finalement tenu bon. L’intérêt de l’opération est intact, assurent-ils en chœur. "Depuis janvier dernier, nous avons été à l’écoute de nos actionnaires et avons pris en compte leurs remarques quand elles sont constructives, assure Ross McInnes, cité dans le communiqué. Nous sommes absolument convaincus de la logique stratégique de l’opération". A en croire le groupe, l’intégration de Zodiac par Safran devrait même permettre de résoudre plus rapidement la crise de l’activité sièges et intérieurs d’avions. "J’ai personnellement visité récemment de nombreux sites industriels de Zodiac en Europe et aux Etats-Unis pour vérifier que les compétences de Safran permettront de résoudre les difficultés actuelles", indique Philippe Petitcolin dans le communiqué. Ross McInnes a toutefois reconnu que le redressement des marges de Zodiac pourrait prendre "un ou deux ans" de plus qu'envisagé en janvier dernier. "Il y aura probablement une perte de marchés, mais les fondamentaux sont bons", assure le président du conseil de Safran.200 millions de synergies annuellesPour le reste, les dirigeants du groupe ont bien pris garde de rassurer les actionnaires du groupe. Un, Safran a maintenu son objectif de 200 millions d’euros de synergies par an, dont 90% trois ans après la fin de l’opération, et 100% à horizon de cinq ans, grâce à "l’optimisation des implantations internationales", en clair la rationalisation des nombreuses usines de Zodiac. Deux, il a confirmé sa promesse de lancer un programme de rachat d’actions à hauteur de 2,3 milliards d’euros sur deux ans. Trois, il assure vouloir continuer de verser 40% de son résultat net en dividendes, et promet de rester dans la catégorie investment grade des agences de notation.La voie semble donc libre pour une finalisation de l’offre début janvier 2018. De quoi contenter les deux camps: Safran met la main sur une cible convoitée de longue date, qui avait refusé ses avances à plusieurs reprises. Quant à Zodiac, il s'épargne le traumatisme d'un échec de l'opération. Le groupe avait confié fin avril le développement d'un plan B, basé sur le maintien de l'indépendance du groupe, à l'ex-PDG de Faurecia Yann Delabrière. Mais ce scénario aurait probablement abouti à une chute brutale du titre Zodiac, les marchés ne cachant plus leur méfiance pour un groupe qui a cumulé onze avertissements sur résultats en deux ans et demi.Départ de Zarrouati après l'opérationLe président du directoire de Zodiac Olivier Zarrouati, qui devait devenir numéro deux du groupe fusionné selon les termes de la première offre, devrait finalement lâcher les rênes du groupe une fois l'opération finalisée. Quant aux actionnaires familiaux de Zodiac, ils devraient apporter leurs titres à l’offre de Safran. "La majorité devrait opter pour l’offre en titres, et donc devenir actionnaires de Safran", assure une source proche de Zodiac. Seuls quelques actionnaires familiaux (5% du capital maximum) devraient rester actionnaires de Zodiac pour une durée indéterminée, en attendant le lancement d’une opération de retrait obligatoire.